Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2005
11/17/2005WO2003073935A3 Breath collection system
11/17/2005WO2003042399A8 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/17/2005US20050257290 Nematode fatty acid desaturase-like sequences
11/17/2005US20050257280 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide
11/17/2005US20050257278 Transgenic non-human animals expressing a truncated activin type II receptor
11/17/2005US20050256815 Medical applications of adaptive learning systems using gene expression data
11/17/2005US20050256739 Radio frequency based remote health monitoring
11/17/2005US20050256652 Reconstruction of gene networks from time-series microarray data
11/17/2005US20050256651 Algorithm for estimation of multiple faults on a transmission line or waveguide
11/17/2005US20050256649 High throughput correlation of polymorphic forms with multiple phenotypes within clinical populations
11/17/2005US20050256647 Mud gas isotope logging interpretative process utilizing mixing lines in oil and gas drilling operations
11/17/2005US20050256646 Mud gas isotope logging interpretive method in oil and gas drilling operations
11/17/2005US20050256525 Dilation introducer for orthopedic surgery
11/17/2005US20050256397 Csf biomarker dilution factor corrections by mri imaging and algorithm
11/17/2005US20050256382 Strip ejector
11/17/2005US20050256207 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
11/17/2005US20050256179 Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
11/17/2005US20050256048 Selective androgen receptor modulators and methods for their identification, design and use
11/17/2005US20050256046 obtaining a sequence-defined molecular weight markers that provide an accurate and robust calibration set for determinations of molecular weight of production batches; subjecting the molecular weight markers to column chromatography to establish a relationship between retention time and molecular weight
11/17/2005US20050256044 Gastrointestinal proliferative factor and uses thereof
11/17/2005US20050256043 chemokines; open reading frames; long terminal repeats; site directed mutagenesis; antibodies
11/17/2005US20050256036 Gastrointestinal proliferative factor and uses thereof
11/17/2005US20050256033 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
11/17/2005US20050255608 Bulking materials containing starch reagent for use in test devices
11/17/2005US20050255607 Scent identification apparatus and method
11/17/2005US20050255605 for controlling emissions from a boiler, power plant, or any facility that generates NOx-containing flue gases is monitored by one or more modules that operate on-line without disrupting the normal operation of the facility; suitable reductants e.g.ammonia gas, a mixture of ammonia and air, aqueous urea
11/17/2005US20050255602 Test kit and process for producing the same
11/17/2005US20050255601 Determining coagulation time; thrombin, prothrombin, partial thromboplastin, or activated clotting times, using a test cartridge with agitator vane leaflets that can be swept through the test sample in the absence of coagulation; resistance to agitator movement due to coagulation is detected
11/17/2005US20050255595 Genetically modified non-human mammal cells, procedure for their production and use in toxicity tests
11/17/2005US20050255579 Process for hydrophilizing surfaces of fluidic components and systems
11/17/2005US20050255578 Device for analyzing constituents of a sample
11/17/2005US20050255576 PGDS inhibitor; antiallergies, sleep control, antiobesity and brain wound healing; Crystals of a complex of human origin hematopoietic prostaglandin D synthase, glutathione and a substrate analog or an inhibitor
11/17/2005US20050255573 An in vitro method of maintaining a mouse or human pluripotent cell in a pluripotent state by increasing expression of a gene that encodes a factor which acts intracellularly and maintainspluripotency, where the factor is a polypeptide of the sequence of SEQ ID NO: 4; cultures
11/17/2005US20050255559 Isolated nucleic acid molecule(s) encoding a human calcium sensitive potassium channel subunit protein designated beta2, encoded proteins, and uses thereof
11/17/2005US20050255540 Buffer system for formalin fixatives
11/17/2005US20050255538 Methods for screening for AcrAB efflux pump inhibitors
11/17/2005US20050255537 Method for monitoring treatment with a parathyroid hormone
11/17/2005US20050255536 Method of selectively measuring triglycerides
11/17/2005US20050255535 Assaying coagulation of a sample; accurate determination of the concentration of anticoagulant in a sample such as a blood or plasma sample
11/17/2005US20050255534 Using cyclooxygenase inhibitors to evaluate agonist activated blood and extracellular platelet-release
11/17/2005US20050255533 Comprehensive food allergy test
11/17/2005US20050255532 Antibodies that immunospecifically bind to B lymphocyte stimulator
11/17/2005US20050255531 Signal transduction
11/17/2005US20050255530 Identification and isolation of pluripotency determining factors
11/17/2005US20050255529 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/17/2005US20050255528 Amine-reactive quaternary acridinium compounds, e.g., pentafluorophenyloxy-1-carbonyl-4,7,10,13-tetraoxapentadecyl-(15-amino)-3'-sulfonyl-2',6'-dimethylphenyl-N-(3-sulfopropyl)-acridinium-9-carboxylate with increased solubility; chemiluminescent conjugates, especially with antibodies; assay kits
11/17/2005US20050255527 screening for biological targets, using a combination of an enyzyme-linked immunoassay and electrochemiluminescence assay to identify antibodies or antigen binding fragments
11/17/2005US20050255526 Anti-tag antibody chip for protein interaction analysis
11/17/2005US20050255525 Safe method for isolation of prion protein and diagnosis of transmissible spongiform encephalopathies
11/17/2005US20050255524 Microparticle-based methods and systems and applications thereof
11/17/2005US20050255523 Analyzing the identification and the concentration of particular target analytes; biological and chemical assays, receptor binding assay; bioassay of proteins, nucleic acids, peptide nucleic acids, biological cells, microorganisms
11/17/2005US20050255519 Reagents and methods useful for detecting diseases of the prostate
11/17/2005US20050255518 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
11/17/2005US20050255517 Methods and devices for multiplexing amplification reactions
11/17/2005US20050255516 Method for quantitative analysis of a nucleic acid amplification reaction
11/17/2005US20050255515 Biomolecular sensors and detection methods utilizing photoinduced charge separation
11/17/2005US20050255514 For depositing a monolayer of such silane molecules onto a substrate; such a monolayer of silane molecules may be used in biosensors, DNA/protein micro-arrays or other sensor applications
11/17/2005US20050255512 Incubating sample with probe having secondary structure that changes upon binding; nuclease cleavage; releasing signal generating fragment
11/17/2005US20050255511 Fra-1 expression in brain cancer
11/17/2005US20050255510 Fra-1 expression in brain cancer
11/17/2005US20050255509 In vivo measurement of the relative fluxes through ribonucleotide reductase vs. deoxyribonucleoside pathways using isotopes
11/17/2005US20050255508 System, method and software arrangement for bi-allele haplotype phasing
11/17/2005US20050255503 Systems and methods for detecting and regulating metastasis
11/17/2005US20050255502 Screening agents which modulate formation of FANCD2-containing foci; cell expressing polynucleotide comprising DNA sequence encoding protein
11/17/2005US20050255500 Determining subcellular distribution of Disrupted-in Schizophrenia-1 (DISC1) protein in cells to predict susceptibility of an individual to schizophrenia, bipolar disorder, major depression or substance abuse; haplotypes
11/17/2005US20050255496 Ztnf12, a tumor necrosis factor
11/17/2005US20050255491 Small molecule and peptide arrays and uses thereof
11/17/2005US20050255488 NTRK1 genetic markers associated with age of onset of Alzheimer's Disease
11/17/2005US20050255487 Methods and compositions for selecting siRNA of improved functionality
11/17/2005US20050255484 Diagnostic markers of stroke and cerebral injury and methods of use thereof
11/17/2005US20050255483 System and method for smoothing melting curve data
11/17/2005US20050255479 Method of detecting and predicting bronchodilatory response to beta agonist
11/17/2005US20050255474 Substrate for bioassay, substrate information reader, and substrate information reading method
11/17/2005US20050255473 Methods, devices and kits for multiplex blotting of biological samples from multi-well plates
11/17/2005US20050255472 Molecule analyzing method using microchannel
11/17/2005US20050255469 Human 5-ht7 receptor promoter sequence
11/17/2005US20050255468 Determination of the level of high risk HPV encoded gene-products such as e.g. HPV E2 and/or HPV E7 molecules in biological samples in the course of cytological testing procedures
11/17/2005US20050255465 Novel fluorescent label compounds
11/17/2005US20050255464 Methods for the identification of peptidyl compounds interacting with extracellular target molecules
11/17/2005US20050255461 Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E
11/17/2005US20050255460 Detecting presence of human papillomavirus E6 proteins using polypeptide comprising modular protein domains (PDZ); screening for cell proliferative disorders
11/17/2005US20050255459 Process and apparatus for using the sets of pseudo random subsequences present in genomes for identification of species
11/17/2005US20050255458 Drug discovery assays based on the biology of chronic disease
11/17/2005US20050255453 Multilayer reagent test strips and methods for using the same to quantify glycated protein in a physiological sample
11/17/2005US20050255452 Using reporter fusions as tools in monitoring protein-protein interactions
11/17/2005US20050255451 Toll-like receptor 9 modulators
11/17/2005US20050255450 contacting a yeast cell with a candidate agent, wherein the yeast cell expresses an alpha synuclein polypeptide and the cell does not express an endogenous wild-type gene, which causes or enhances toxicity associated with the presence of the alpha synuclein polypeptide
11/17/2005US20050255447 Made of processed blood cells for simulating human immature granulocytes and a suitable suspension medium; impedance, light scatter and axial light loss measurements
11/17/2005US20050255446 Perfusion system and apparatus for automated multi-channel patch-clamp recordings utilizing inside-out whole-cell configuration
11/17/2005US20050255445 Method for high throughput cell-based assays using versatile living microarrays
11/17/2005US20050255443 Method of screening cell growth inhibitor and cell growth inhibitor
11/17/2005US20050255182 Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation
11/17/2005US20050255125 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
11/17/2005US20050255114 Methods and diagnosis for the treatment of preeclampsia
11/17/2005US20050255105 Severe myelin deficits induced by self-reactive gamma delta T cells
11/17/2005US20050255102 binds to alpha v beta 6 and not other alpha v integrins or non-specific integrins; inhibits the binding of alpha v beta 6 to latency associated peptide with an IC50 value lower than that of 10D5 and binds alpha v beta 6 in manner that does not distinguish between the use of Ca2+/Mg2+ and Mn2+ for cation
11/17/2005US20050255101 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
11/17/2005US20050255090 High enzyme activity; screening its relative symbiotic bacteria using a specific antibody
11/17/2005US20050255089 adeno-associated virus 5 (AAV5) specific polynucleotides, that codes for an AAV5 specific proteins; delivering polynucleotides to cells using the AAV5 vectors and particles
11/17/2005US20050255041 Administering monoclonal antibody or antigen binding fragment accession number 270404-01; primary and metastatic tumors
1 ... 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 ... 3937